Steve Swallow
AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Poland)(PL)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Synthesis and biological activity, Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies
Most-Cited Works
- → Fluorine in medicinal chemistry(2007)7,325 cited
- → In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs(2012)212 cited
- → Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)(2016)81 cited
- → Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)(2019)77 cited
- → Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules(2011)57 cited
- → Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point(2017)52 cited